No Results Found
Try adjusting your search to find what you’re looking for.
2/15/2022
Kallyope Raises $236M Series D Financing to Fuel Expansion of Novel Gut-Brain Axis Therapeutic Programs
Kallyope, Inc., a leading biotechnology company focused on identifying and developing therapeutics involving the gut-brain axis, today announced the closing of a $236 million Series D financing co-led by Mubadala Investment Company and The Column Group, along with participation from other new and existing investors (including Illumina Ventures). The funds will be used to advance the company’s ...
Read More
1/20/2022
Protillion Biosciences Closes $18M Series A Round
Biotech firm Protillion Biosciences has closed an $18 million Series A financing round funded by Arch Venture Partners and Illumina Ventures.
Read More
12/15/2021
Company Spotlight – Alamar
“While most liquid biopsy efforts focus on circulating tumor DNA (ctDNA), Alamar is taking a different path, looking for circulating cancer-associated protein biomarkers,” said Nick Naclerio, Ph.D., Founding Partner of Illumina Ventures. “This is mostly undiscovered territory and could ultimately lead to highly sensitive diagnostics that find cancer and other diseases early when they are most ...
Read More
11/23/2021
Genomeweb: Stilla Technologies Raises €31.3M In Financing
Stilla Technologies announced on Tuesday it has raised €31.3 million ($35.2 million) in new funding. The Paris-based firm will use the funds to expand its global commercial presence and develop its next-generation digital PCR platform.
Read More
